Physician

Jonathan Ticku, M.D.

According to 2025 Medicare claims, Jonathan Ticku, M.D. (NPI: 1922259589) practices hematology/oncology in the La Crosse-Onalaska, WI-MN market, with the plurality of this provider's patient population coming from La Crosse, WI. This provider's primary affiliated billing organization is MAYO CLINIC HEALTH SYSTEM-SOUTHWEST WISCONSIN REGION, INC. (NPI: 1629056049; TIN: 390806374) and primary practice location at 54601-8806. Ticku is affiliated with the Mayo Clinic Community ACO, LLC (ACO ID: A4617), Caravan Health ACO 50 LLC (ACO ID: A5160), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Ticku's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 297 traditional Medicare patients, billed 987 HCPCS/CPT codes, and received $71,294 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 722 prescription claims across 132 beneficiaries totaling $2,224,535 in drug costs, led by Revlimid (Lenalidomide). 2022 DME data shows 27 claims. Open Payments data shows 2 records totaling $610. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $82,864 to $71,294. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $665,249 to $2,224,535. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $3,354 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	294	966	$82,864
2016	529	1,959	$117,607
2017	520	3,209	$88,533
2018	376	4,470	$83,503
2019	431	1,774	$72,849
2020	445	1,231	$68,901
2021	433	1,164	$89,999
2022	386	799	$49,023
2023	301	785	$64,089
2024	297	987	$71,294

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	127	735	$665,249
2016	153	984	$1,428,193
2017	156	1,029	$1,886,377
2018	158	1,020	$1,914,415
2019	182	1,125	$2,406,579
2020	211	1,162	$3,074,152
2021	229	1,313	$5,172,127
2022	197	954	$3,676,959
2023	147	789	$2,788,468
2024	132	722	$2,224,535

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	158	$27,103
2016	N/R	151	$14,272
2017	N/R	205	$23,444
2018	N/R	77	$8,696
2019	N/R	N/R	N/R
2020	N/R	39	$3,917
2021	N/R	24	$3,901
2022	N/R	27	$432
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	116	253	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	167	279	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	52	66	$64
99451	Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes	36	36	$25
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	118	246	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	19	504	$312,919
Xtandi	Enzalutamide	23	690	$281,226
Erleada	Apalutamide	12	345	$165,389
Cabometyx	Cabozantinib S-Malate	11	283	$162,176
Imbruvica	Ibrutinib	13	364	$141,494

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$610	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jonathan Ticku, M.D.?

Tedicare shows public-source Medicare data for Jonathan Ticku, M.D. (NPI 1922259589), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jonathan Ticku, M.D. have ACO affiliation data?

Jonathan Ticku, M.D. is shown with ACO affiliation data for Mayo Clinic Community ACO, LLC (MSSP, ACO ID A4617), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Jonathan Ticku, M.D.?

Jonathan Ticku, M.D. is linked to MAYO CLINIC HEALTH SYSTEM-SOUTHWEST WISCONSIN REGION, INC. (billing NPI 1629056049) in the available physician profile data.

Does Jonathan Ticku, M.D. have Open Payments data?

Jonathan Ticku, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.